616466  InhibitorSelect™ TGF-βR and BMPR Signaling Pathway Inhibitor Panel

A panel containing 18 potent, selective and cell-permeable inhibitors that are useful for the study of TGF-βR and BMPR signaling pathway: 2 mg of Akt Inhibitor XIII, Isozyme-Selective, Akti2-1/2 (Cat. No. 124030), 1 mg of Dorsomorphin (AMPK Inhibitor, Compound C; Cat. No. 171260), 5 mg of ET-18-OCH3 (Cat. No. 341207), 5 mg of IRAK-1/4 Inhibitor (Cat. No. 407601), 500 µg of JAK Inhibitor I, Pyridone 6 (Cat. No. 420099), 5 mg of MG-132 (Cat. No. 474790), 1 mg of (5Z)-7-Oxozeaenol, Curvularia sp. (Cat. No. 499610), 5 mg of p21-Activated Kinase Inhibitor III, IPA-3 (Cat. No. 506106), 1 mg of PD 169316 (Cat. No. 513030), 1 mg of PI-103 (Cat. No. 528100), 5 mg of Rac1 Inhibitor (Cat. No. 553502), 500 µg of Ro-31-8220 (Cat. No. 557520), 1 mg of Smad3 Inhibitor, SIS3 (Cat. No. 566405), 10 mg of STAT3 Inhibitor III, WP1066 (Cat. No. 573097), 1 mg of TGF-β RI Kinase Inhibitor II (Cat. No. 616452), 5 mg of TGF-β RI Kinase Inhibitor VI, SB431542 (Cat. No. 616461), 1 mg of U0126 (Cat. No. 662005), 1 mg of Y-27632 (Cat. No. 688000). Also provided with 15 ml of anhydrous DMSO (Cat. No. KP31817). Supplied with a data sheet.